about
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Ico...
Read More
108.14
2.01
(1.89%)
1.4M
XNAS Volume
XNAS 27 Feb, 2026 4:30 PM (EST)
High Financial Strength
Mid Valuation
Technically Bearish
Falling Comet
These stocks have good quality scores. However, their weak technicals make them more bearish
View Similar
Embed DVM
Icon PLC Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..